NIHR MedTech and In Vitro Diagnostics Co-operatives (MICs) build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. Leading NHS organisations act as centres of expertise, bringing together patients, clinicians, researchers, commissioners and industry.
More than £14 million over 5 years has been awarded across 11 NIHR MICs:
- NIHR London In Vitro Diagnostics Co-operative (NIHR London IVD Co-operative)
- NIHR Leeds In Vitro Diagnostics Co-operative (NIHR Leeds IVD Co-operative)
- NIHR Newcastle In Vitro Diagnostics Co-operative (NIHR Newcastle IVD Co-operative)
- NIHR Surgical MedTech Co-operative
- NIHR Brain Injury MedTech Co-operative
- NIHR Cardiovascular MedTech Co-operative
- NIHR Devices for Dignity MedTech Co-operative (NIHR D4D MedTech Co-operative)
- NIHR Mental Health MedTech Co-operative (NIHR MindTech MedTech Co-operative)
- NIHR Trauma Management MedTech Co-operative (NIHR Trauma MedTech Co-operative)
- NIHR Children and Young People MedTech Co-operative (NIHR CYP MedTech Co-operative)
- NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative (NIHR Community Healthcare MedTech and IVD Co-operative)
The NIHR MICs launched on 1 January 2018. The NIHR MICs replace the NIHR Healthcare Technology Co-operatives (HTCs) and NIHR Diagnostic Evidence Co-operatives (DECs), incorporating and retaining the remits of both.